Abstract
Background
End-stage renal disease is considered to influence coronary microcirculation and left ventricular (LV) diastolic function. We investigated whether differences exist in LV diastolic function indices and coronary flow reserve (CFR) between patients on hemodialysis (HD) and peritoneal dialysis (PD).
Methods
A complete transthoracic echocardiographic study was performed on 21 HD and 22 PD patients and LV diastolic function was evaluated. CFR was estimated using transthoracic Doppler echocardiography on the left anterior descending artery, during high-dose dypiridamole infusion.
Results
HD and PD groups did not differ regarding Doppler-derived diastolic indices, but they significantly differed in the frequency of severe LV hypertrophy (38.1% in HD vs 4.5% in PD group, p = 0.009) and grade II diastolic dysfunction (42.9% in HD vs 4.5% in PD group, p = 0.004). No patient had restrictive filling pattern. There was no difference in the prevalence of arterial hypertension and diabetes mellitus in patients with grade II vs less than grade II dysfunction. Mean CFR was similar in the HD and PD groups (2.25 ± 0.65 vs 2.36 ± 0.76, p = 0.635) and lower in patients with grade II diastolic dysfunction (1.87 ± 0.43 vs 2.44 ± 0.72, p = 0.023) and diabetes (1.70 ± 0.59 vs 2.39 ± 0.68, p = 0.04). LV mass index was negatively associated with CFR (r = − 0.308, p = 0.045).
Conclusion
Patients on HD had more advanced diastolic dysfunction compared to PD, independently of the presence of hypertension and diabetes. CFR did not differ between HD and PD patients, but it was significantly lower in diabetics and in patients with more advanced diastolic dysfunction.
Similar content being viewed by others
References
Antlanger M, Aschauer S, Kopecky C, et al. Heart Failure with preserved and reduced ejection fraction in hemodialysis patients: prevalence, disease prediction and prognosis. Kidney Blood Press Res. 2017;42(1):165–76.
Wu CK, Lee JK, Wu YF, et al. Left ventricular diastolic dysfunction in peritoneal dialysis: a forgotten risk factor. Medicine (Baltimore). 2015;94(20):e819.
Han JH, Han JS, Kim EJ, et al. Diastolic dysfunction is an independent predictor of cardiovascular events in incident dialysis patients with preserved systolic function. PLoS ONE. 2015;10(3):e0118694.
Pecoits-Filho R, Bucharles S, Barberato SH. Diastolic heart failure in dialysis patients: mechanisms, diagnostic approach, and treatment. Semin Dial. 2012;25(1):35–41.
Barberato SH, Bucharles SG, Sousa AM, et al. Prevalence and prognostic impact of diastolic dysfunction in patients with chronic kidney disease on hemodialysis. Arq Bras Cardiol. 2010;94(4):457–62.
de Bie MK, Ajmone Marsan N, Gaasbeek A, et al. Left ventricular diastolic dysfunction in dialysis patients assessed by novel speckle tracking strain rate analysis: prevalence and determinants. Int J Nephrol. 2012;2012:963504.
Rosello A, Torregrosa I, Solis MA, et al. Study of diastolic function in peritoneal dialysis patients. Comparison between pulsed doppler and tissue doppler. Nefrologia. 2007;27(4):482–8.
Kimura H, Takeda K, Tsuruya K, et al. Left ventricular mass index is an independent determinant of diastolic dysfunction in patients on chronic hemodialysis: a tissue doppler imaging study. Nephron Clin Pract. 2011;117(1):c67–c73.
Gunal AI, Ilkay E, Kirciman E, et al. Blood pressure control and left ventricular hypertrophy in long-term CAPD and hemodialysis patients: a cross-sectional study. Perit Dial Int. 2003;23(6):563–7.
Ellouali F, Berkchi F, Bayahia R, et al. Comparison of the effects of dialysis methods (haemodialysis vs peritoneal dialysis) on diastolic left ventricular function dialysis methods and diastolic function. Open Cardiovasc Med J. 2016;10:171–8.
Ahmadmehrabi S, Tang WHW. Hemodialysis-induced cardiovascular disease. Semin Dial. 2018;31(3):258–67.
Malyszko J. Mechanism of endothelial dysfunction in chronic kidney disease. Clin Chim Acta. 2010;411(19–20):1412–20.
Meyer C, Heiss C, Drexhage C, et al. Hemodialysis-induced release of hemoglobin limits nitric oxide bioavailability and impairs vascular function. J Am Coll Cardiol. 2010;55(5):454–9.
Gross ML, Ritz E. Hypertrophy and fibrosis in the cardiomyopathy of uremia–beyond coronary heart disease. Semin Dial. 2008;21(4):308–18.
Steeds RP, Wheeler R, Bhattacharyya S, et al. Stress echocardiography in coronary artery disease: a practical guideline from the British Society of Echocardiography. Echo Res Pract. 2019;6(2):G17–G33.
Sicari R, Nihoyannopoulos P, Evangelista A, et al. Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr. 2008;9(4):415–37.
Dimitrow PP, Galderisi M, Rigo F. The non-invasive documentation of coronary microcirculation impairment: role of transthoracic echocardiography. Cardiovasc Ultrasound. 2005;3(18):1476–7120120.
Niizuma S, Takiuchi S, Okada S, et al. Decreased coronary flow reserve in haemodialysis patients. Nephrol Dial Transplant. 2008;23(7):2324–8.
Caliskan Y, Oflaz H, Demirturk M, et al. Coronary flow reserve dysfunction in hemodialysis and kidney transplant patients. Clin Transplant. 2008;22(6):785–93.
Tok D, Gullu H, Erdogan D, et al. Impaired coronary flow reserve in hemodialysis patients: a transthoracic Doppler echocardiographic study. Nephron Clin Pract. 2005;101(4):19.
Nakanishi K, Fukuda S, Shimada K, et al. Prognostic value of coronary flow reserve on long-term cardiovascular outcomes in patients with chronic kidney disease. Am J Cardiol. 2013;112(7):928–32.
Lakkas L, Naka KK, Bechlioulis A, et al. The prognostic role of myocardial strain indices and dipyridamole stress test in renal transplantation patients. Echocardiography. 2020;37(1):62–70.
Tona F, Silvestre C, Rigato M, et al. Coronary microvascular dysfunction predicts long-term outcome in simultaneous pancreas-kidney transplantation. Transplant Proc. 2016;48(2):344–8.
Papamichail N, Bechlioulis A, Lakkas L, et al. Impaired coronary microcirculation is associated with left ventricular diastolic dysfunction in end-stage chronic kidney disease patients. Echocardiography. 2020;00:1–10.
Bozbas H, Pirat B, Demirtas S, et al. Evaluation of coronary microvascular function in patients with end-stage renal disease, and renal allograft recipients. Atherosclerosis. 2009;202(2):498–504.
Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1–39 e14.
Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57(6):450–8.
Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29(4):277–314.
Meimoun P, Tribouilloy C. Non-invasive assessment of coronary flow and coronary flow reserve by transthoracic Doppler echocardiography: a magic tool for the real world. Eur J Echocardiogr. 2008;9(4):449–57.
Simova I. Coronary flow velocity reserve assessment with transthoracic doppler echocardiography. Eur Cardiol. 2015;10(1):12–8.
Zoccali C, Benedetto FA, Mallamaci F, et al. Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. J Am Soc Nephrol. 2001;12(12):2768–74.
Foley RN, Parfrey PS, Harnett JD, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995;47(1):186–92.
Silberberg JS, Barre PE, Prichard SS, et al. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int. 1989;36(2):286–90.
Mitsnefes MM, Daniels SR, Schwartz SM, et al. Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors. Pediatr Nephrol. 2000;14(10–11):898–902.
Tian JP, Wang T, Wang H, et al. The prevalence of left ventricular hypertrophy in Chinese hemodialysis patients is higher than that in peritoneal dialysis patients. Ren Fail. 2008;30(4):391–400.
Enia G, Mallamaci F, Benedetto FA, et al. Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients. Nephrol Dial Transplant. 2001;16(7):1459–64.
Lai S, Molfino A, Russo GE, et al. Cardiac, inflammatory and metabolic parameters: hemodialysis versus peritoneal dialysis. Cardiorenal Med. 2015;5(1):20–30.
Foley RN, Parfrey PS, Harnett JD, et al. Mode of dialysis therapy and mortality in end-stage renal disease. J Am Soc Nephrol. 1998;9(2):267–76.
Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol. 1999;10(7):1606–15.
Wang AY, Wang M, Lam CW, et al. Left ventricular filling pressure by Doppler echocardiography in patients with end-stage renal disease. Hypertension. 2008;52(1):107–14.
Kibel A, Selthofer-Relatic K, Drenjancevic I, et al. Coronary microvascular dysfunction in diabetes mellitus. J Int Med Res. 2017;45(6):1901–29.
Funding
The authors received no financial support for the research, authorship, and publication of this article.
Author information
Authors and Affiliations
Contributions
IG: study conception, data acquisition, data analysis, and manuscript preparation. KKN and ED: study conception and design, critical appraisal, and study supervision. LL: study design, data acquisition, and critical appraisal. PM, AD, KK, and RK: enrollment process, data acquisition, and critical appraisal. LKM: critical appraisal and study supervision. CSK: study conception, data analysis, manuscript preparation, and study supervision. All authors provided important intellectual content to this work.
Corresponding author
Ethics declarations
Conflict of interest
Ioannis Gkirdis, Katerina K. Naka, Lampros Lakkas, Panagiota Manolakaki, Anila Duni, Konstantinos Koulousios, Rigas Kalaitzidis, Evangelia Dounousi, Lampros K. Michalis, and Christos S. Katsouras declare that they have no conflict of interest.
Human rights statement
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions.
Informed consent
Informed consent was obtained from all patients for being included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Gkirdis, I., Naka, K.K., Lakkas, L. et al. Coronary microcirculation and left ventricular diastolic function: comparison between patients on hemodialysis and peritoneal dialysis. J Echocardiogr 19, 103–112 (2021). https://doi.org/10.1007/s12574-020-00493-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12574-020-00493-7